Limits...
Development of UK guidance on the management of erectile dysfunction resulting from radical radiotherapy and androgen deprivation therapy for prostate cancer.

White ID, Wilson J, Aslet P, Baxter AB, Birtle A, Challacombe B, Coe J, Grover L, Payne H, Russell S, Sangar V, Van As N, Kirby M - Int. J. Clin. Pract. (2014)

Bottom Line: This article offers a comprehensive treatment algorithm to manage patients with ED associated with RT/ADT.Based on published research literature and survey analysis, recommendations are proposed for the standardisation of management strategies employed for ED after RT/ADT.In addition to implementing the algorithm, understanding the rationale for the type and timing of ED management strategies is crucial for clinicians, men and their partners.

View Article: PubMed Central - PubMed

Affiliation: Urology Unit, The Royal Marsden NHS Foundation Trust, London & Sutton, UK.

No MeSH data available.


Related in: MedlinePlus

Prostate cancer NICE guidelines 72. *Sexual function term used by NICE though the treatments are solely for erectile dysfunction
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4309408&req=5

fig06: Prostate cancer NICE guidelines 72. *Sexual function term used by NICE though the treatments are solely for erectile dysfunction

Mentions: The NICE consultation guidelines on Prostate Cancer recommend offering PDE5-Is to men who experience loss of EF 72. Furthermore, NICE recommend that if PDE5-Is fail to restore EF, or are contraindicated, men should be offered a choice of intraurethral inserts, penile injections, penile prosthesis or vacuum devices (VED). However, NICE do not specify the order of ED management interventions nor do they specify strategies according to specific prostate cancer treatment modality and patient demographics (Figure6) 72.


Development of UK guidance on the management of erectile dysfunction resulting from radical radiotherapy and androgen deprivation therapy for prostate cancer.

White ID, Wilson J, Aslet P, Baxter AB, Birtle A, Challacombe B, Coe J, Grover L, Payne H, Russell S, Sangar V, Van As N, Kirby M - Int. J. Clin. Pract. (2014)

Prostate cancer NICE guidelines 72. *Sexual function term used by NICE though the treatments are solely for erectile dysfunction
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4309408&req=5

fig06: Prostate cancer NICE guidelines 72. *Sexual function term used by NICE though the treatments are solely for erectile dysfunction
Mentions: The NICE consultation guidelines on Prostate Cancer recommend offering PDE5-Is to men who experience loss of EF 72. Furthermore, NICE recommend that if PDE5-Is fail to restore EF, or are contraindicated, men should be offered a choice of intraurethral inserts, penile injections, penile prosthesis or vacuum devices (VED). However, NICE do not specify the order of ED management interventions nor do they specify strategies according to specific prostate cancer treatment modality and patient demographics (Figure6) 72.

Bottom Line: This article offers a comprehensive treatment algorithm to manage patients with ED associated with RT/ADT.Based on published research literature and survey analysis, recommendations are proposed for the standardisation of management strategies employed for ED after RT/ADT.In addition to implementing the algorithm, understanding the rationale for the type and timing of ED management strategies is crucial for clinicians, men and their partners.

View Article: PubMed Central - PubMed

Affiliation: Urology Unit, The Royal Marsden NHS Foundation Trust, London & Sutton, UK.

No MeSH data available.


Related in: MedlinePlus